Jan Fehr
0000-0003-1113-9895
172 papers found
Refreshing results…
Ability to work and employment rates in human immunodeficiency virus (HIV)-1-infected individuals receiving combination antiretroviral therapy: The Swiss HIV cohort study
Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges
‘If at first you don't succeed, try again’. Looking beyond the initial results of a failed tuberculosis diagnosis
Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues:
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period.
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
Brief Report
Switch to etravirine for HIV-positive patients receiving statin treatment: A prospective study
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults:
Gelbe Flecken und wie weiter?
“Fighting an uphill battle”: experience with the HCV triple therapy: a qualitative thematic analysis
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients
Virologic and Immunologic Responses in Treatment-Naive Patients to Ritonavir-Boosted Atazanavir or Efavirenz With a Common Backbone
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Infections With the Tick-Borne Bacterium "Candidatus Neoehrlichia mikurensis" Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases
[Limitations of medicine:diagnosis and therapy of <> back pain].
Co-Trimoxazole Prophylaxis Is Associated with Reduced Risk of Incident Tuberculosis in Participants in the Swiss HIV Cohort Study
Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study:
Missing publications? Search for publications with a matching author name.